Company Filing History:
Years Active: 2022-2025
Title: Innovations and Contributions of Inventor Jingdong Qin
Introduction
Jingdong Qin is a notable inventor based in Woodridge, IL (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents for cancer treatment. With a total of 3 patents, his work focuses on innovative methods and compositions that target specific cancer-related proteins.
Latest Patents
Jingdong Qin's latest patents include groundbreaking work on binding molecules specific for claudin 18.2. These compositions and methods are designed for the treatment of various cancers, including gastric, esophageal, pancreatic, lung, ovarian, colon, hepatic, head-neck cancers, and gallbladder cancer. His patents describe pharmaceutical formulations that utilize these binding molecules either as standalone agents or in combination with other anticancer therapies, such as immune checkpoint inhibitors. Additionally, he has developed bispecific antibodies that target both human claudin 18.2 and programmed death-ligand 1 (PD-L1), further enhancing the potential for effective cancer treatments.
Career Highlights
Jingdong Qin is currently associated with Sparx Bioscience Limited, where he continues to advance his research and development efforts. His innovative approach to cancer therapeutics has positioned him as a key figure in the biotechnology sector. His work not only contributes to scientific knowledge but also has the potential to improve patient outcomes in cancer treatment.
Collaborations
Jingdong Qin collaborates with esteemed colleagues, including Guidong Zhu and Jingdong Ye. These partnerships enhance the research capabilities and foster innovation within their projects.
Conclusion
Jingdong Qin's contributions to the field of biotechnology, particularly in cancer treatment, highlight his role as a leading inventor. His innovative patents and ongoing research efforts continue to pave the way for advancements in therapeutic solutions.